Position in TNDM
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$13,353,630
-$938,865 QoQ
Shares Held
696,590
+7.1% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNDM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $183,504,116 across 22 Medical Devices names. TNDM ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMDX |
TransMedics Group, Inc.
|
244,382 | $24,294,014 | |
| 2 | ESTA |
Establishment Labs Holdings Inc.
|
427,472 | $24,271,860 | |
| 3 | AORT |
Artivion, Inc.
|
425,282 | $15,573,826 | |
| 4 | BVS |
Bioventus Inc.
|
1,541,282 | $14,071,904 | |
| 5 | ENOV |
Enovis CORP
|
611,090 | $13,902,297 | |
| 6 | TNDM |
Tandem Diabetes Care Inc
This page
|
696,590 | $13,353,630 | |
| 7 | APYX |
Apyx Medical Corp
|
2,611,224 | $9,635,416 | |
| 8 | CBLL |
Ceribell, Inc.
|
515,720 | $9,453,147 |
All Filings in TNDM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,353,630 | 696,590 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $14,292,495 | 650,250 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,191,400 | 510,000 | Shares | Sole | 2025-11-12 | |
| 2021-06-30 | $7,625,056 | 78,286 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,035,064 | 68,386 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $6,418,788 | 67,086 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,004,961 | 35,286 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,333,127 | 23,586 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,418,659 | 37,586 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||